Journals / Retina-Vitreus / 2003 / Cilt: 11 - Sayı: 1

Twelve months results of photodynamic therapy for classic versus occult chorodial neovascularization in patients with age-related macular degeneration

Klasik koroid neovaskülerizasyonlu ve gizli koroid neovaskülerizasyonlu yaşa bağlı makula dejenerasyonu olgularındaki fotodinamik tedavi uygulamasının 12 aylık takip sonuçları

Pages
13–18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Both groups have also almost the same retreatment rates.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The aim of this study is to compare the 12 months results of photodynamic therapy in two different groups of choroidal neovascularization (classic versus occult) caused by age-related macular degeneration.
📊
Key Findings & Data:Follow-up examination were scheduled at 1 month, at 3 months after the treatment and thereafter every 3 months.
💡
Conclusion & Impact:Both groups have also almost the same retreatment rates.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Geriyedönük çalışma · Görme keskinliği · İzleme çalışmaları

Abstract

Purpose: The aim of this study is to compare the 12 months results of photodynamic therapy in two different groups of choroidal neovascularization (classic versus occult) caused by age-related macular degeneration. Materials and Methods: Visual acuity testing, systemic ophthalmologic examination, color photographs, fluorescein and indocyanine green angiography were used to evaluate the results of photodynamic therapy with verteporfin. Follow-up examination were scheduled at 1 month, at 3 months after the treatment and thereafter every 3 months. Retreatments were considered when moderate leakage or the progression of the leakage was observed at 3 months intervals. All patients completed the month 12 examination. Results: Fifteen patients with classic CNV (group A) and 15 patients with occult CNV (group B) were compared. All patients completed the month 12 examination. At the month 12 examination, in group A, 3 (20%) patients, in group B 4 (26,6%) patients had improved in visual acuity. In group A, 2 (13,3%) patients, in group B 3 (20%) patients had some deterioration in visual acuity. In group A, 3 (20%) patients, in group B, 2 (13,3%) patients show no CNV within the area of the lesion noted at baseline at the month 12 examination. Progression of CNV beyond the area of the lesion identified at baseline at the month 12 examination occured in 1 (6,6%) patients in group A, compared with 2 (13,3%) patients in group B. Mean treatment sessions were 1.6 in group A, 1.5 in group B. Conclusion: Visual acuity benefit through 12 months of follow-up was very similar in both group. These outcomes were also accompained by fluoescein angiography outcome at 12 months of follow-up. Both groups have also almost the same retreatment rates.

Özet

Amaç: Bu çalışmanın amacı, yaşa bağlı makula dejenerasyonu sonucu gelişen subfoveal koroid neovaskülerizasyonlarmm farklı iki tipinde (klasik, gizli) fotodinamik tedavinin 12 aylık sonuçlarını değerlendirmektir. Gereç ve Yöntem: Fotodinamik tedavi sonuçları değerlendirilirken olguların her kontrolde görme keskinliği ve sistemik oftalmolojik muayenesi yapıldı; renkli fundus fotoğrafları, floresein ve indosiyanin yeşili anjiografileri çekildi. Tedavi sonrası olgular birinci ve üçüncü aylarda ve daha sonraki takiplerde ise üçer ay aralar ile kontrollere alındı. Tedavi sonrası üçüncü aydaki muayenesinde koroid neovaskülerirasyonunda orta derecede sızıntı ya da ilerleme izlenen olgularda tedavi protokolü tekrarlandı. Bulgular: Klasik koroid neovaskülerizasyonu olan 15 olgu (grup A) ile gizli koroid neovaskülerizasyonu olan 15 olgu (grup B) karşılaştırıldı. Tüm olgular 12 aylık takip sürelerini tamamlamışlardı. Onikinci aydaki muayenede grup A'da 3 olguda (%20), grup B'de 4 olguda (%26.6) görme keskinliğinde artış olduğu gözlendi. Grup A'da 2 (%13.3), grup B'de 3 olguda (%20) görme keskinliği geriledi. Onikinci aydaki kontrol anjiografilerinde Grup A'da 3 olguda (%20), grup B'de 2 olguda (%13.3) olguda koroid neovaskülerizasyonunda sızıntı olmadığı tespit edildi. Grup A'da 1 olguda (%6.6), grup B'de 2 olguda (%13.3) koroid neovaskülerizasyonunda ilerleme izlendi. Ortalama tedavi sayısı grup A'da 1.6, grup B'de 1.5 idi. Sonuç: Fotodinamik tedavi sonrası 12 aylık takiplerde klasik subfoveal koroid neovaskülerizasyonu ya da gizli subfoveal koroid neovaskülerizasyonu bulunan yaşa bağlı makula dejenerasyonu olgularında görme keskinliğinin korunması açısından benzer yanıtlar elde edilmiştir. Görme keskinliğinde elde edilen olumlu sonuçlar anjiografik olarak elde edilen sonuçlarla parelellik göstermektedir. Her iki gruptaki tekrar tedavi gereksinimi birbirine yakındır.

🔖

Cite This Article

KARAÇORLU, M., KARAÇORLU, S., ÖZDEMİR, H. (2003). Twelve months results of photodynamic therapy for classic versus occult chorodial neovascularization in patients with age-related macular degeneration. Retina-Vitreus, Cilt: 11 - Sayı: 1, 13–18. https://ajindex.com/articles/307954

References (16)

  1. Hyman LG, Lilienfield AM, Ferris F III, et al: Senile macular degeneration: a case control study. Am J Epidemiol 1983; 118:213-227
  2. Klein R, Klein B, Linton K: Prevalence of age-related maculopathy. Ophthalmology 1992;99:933-942
  3. Ferris F III, Fine SL, Hyam LG: Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984; 102:1640-1642
  4. Vingerling J, Dielemans I, Hofmann A: Prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995; 102:205-210
  5. Green WR, Key SN. Senile macular degeneration: a histopathologic study. Trans Am Ophthalmol Soc 1977;75:180-254
  6. Maguire MG: Natural History. In: Berger JW, Fine SL, Maguire MG editors. Age-related Macular Degeneration. St. Louis: Mosby, 1999:17-30
  7. Kwun RC, Guyer DR: Indocyanine Green Angiography. In: Berger JW, Fine SL, Maguire.MC editors. Age-related Macular Degeneration. St Louis: Mosby, 1999:237-247
  8. Schmidt-Erfurth U, Miller J, Sickenberg M, et al: Photodynamic therapy of subfoveal choroidal neovascularization: clinical and angiographie examples. Graefe's Arch Clin Exp Ophthalmol 1998;236:365-374
  9. Richter AM, Cerruti-Sola S, Sternberg ED, et al: Biodistrubition of tritiated benzoporphyrin derivative (3H-BPH-MA), a new potent photosensitizer in normal and tumor-bearing mice. J Photochem Photobiol B 1990;5:231-144
  10. Weishaupt UR, Gorner CJ, Dougherty TJ: Identification of singlet oxygen as the cytotoxic agent in photoinactivation of a murine tumour. Cancer Res 1976;36:2326-2329
  11. Gelişken F, Inhoffen W, Partsch M, et al: Retinal pigment epithelial tear after photodynamic therapy for choroidal neovascularization. Am J Ophthalmol 2001;131:518-520
  12. Hussain D, Miller JW, Michaud N et al: Intravenous infusion of liposomal benzoporphin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996; 114: 978-985
  13. Lutty G A, McLeod DS, Mergers C, et al: Localization of vascular endothelial growth factor in human retina and choroid. Arch Ophthalmol 1996; 114:971-977
  14. Schmidt-Erfurth U, Hasan T: Mechanism of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 2000;45:195-214
  15. Henderson BW, Dougherty TJ: How does photodynamic therapy work? Photochem Photobiol 1992;55:145-157
  16. Treatment of Age-related Macular Degeneration With Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal chor